Skip to main content
Have a personal or library account? Click to login
New Targets for End-Stage Chronic Kidney Disease Therapy Cover

New Targets for End-Stage Chronic Kidney Disease Therapy

The Journal of Critical Care Medicine
Volume 1 (2015): Issue 3 (July 2015)
By: ,   and    
Open Access
|Aug 2015
References

References

  1. 1. Lozano, R. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
    Open DOISearch in Google Scholar
  2. 2. Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, Chatziantoniou C. Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One. 2009;21:e6721.
    Open DOISearch in Google Scholar
  3. 3. Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents. Hypertension. 2013;61:901-7.
    Open DOISearch in Google Scholar
  4. 4. Chatziantoniou C, Dussaule JC. Is kidney injury a reversible process? CurrOpinNephrolHypertens. 2008;17:76-81.
    Search in Google Scholar
  5. 5. Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med. 2009;361:40-51.
    Open DOISearch in Google Scholar
  6. 6. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev. 2001;103:183-8.
    Open DOISearch in Google Scholar
  7. 7. Norris RA, Kern CB, Wessels A, et al. Identification and detection of the periostin gene in cardiac development. AnatRec A Discov Mol CellEvolBiol. 2004;281:1227-33.
    Open DOISearch in Google Scholar
  8. 8. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088-98.
    Open DOISearch in Google Scholar
  9. 9. Naik PK, Bozyk PD, Bentley JK, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012;303:L1046-56.
    Open DOISearch in Google Scholar
  10. 10. Guerrot D, Dussaule JC, Mael-Ainin M, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012;7:e31974
    Open DOISearch in Google Scholar
  11. 11. Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179:1756-67.
    Open DOISearch in Google Scholar
  12. 12. Mael-Ainin M, Abed A, Conway S, Dussaule JC, Chatziantoniou C. Inhibition of Periostin expression protects against the development of renal inflammation and fibrosis. J Am SocNephrol. 2014;25:1724-36.
    Open DOISearch in Google Scholar
  13. 13. Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant.2012;27:2702-11.
    Open DOISearch in Google Scholar
  14. 14. Li L, Fan D, Wang C, et al. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. CardiovascRes. 2011;91:80-89.
    Open DOISearch in Google Scholar
  15. 15. Uchida M, Shiraishi H, Ohta S, et al. Periostin, a matricellularprotein, plays a role in the induction of chemokines in pulmonaryfibrosis. Am J RespirCell Mol Biol. 2012;46:677-86.
    Open DOISearch in Google Scholar
  16. 16. Curat C.A. and Vogel W.F., Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. J Am Soc Nephrol. 2002;13:2648-2656.
    Open DOISearch in Google Scholar
  17. 17. Flamant M, Placier S, Rodenas A, et al. Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. J Am Soc Nephrol. 2006;17:3374-81.
    Open DOISearch in Google Scholar
  18. 18. Kerroch M, Guerrot D, Vandermeersch S, et al. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis. Faseb J. 2012;26:4079-91.
    Open DOISearch in Google Scholar
  19. 19. Guerrot D, Kerroch M, Placier S, et al. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. Am J Pathol. 2011;179:83-91.
    Open DOISearch in Google Scholar
  20. 20. Gross O, Girgert R, Beirowski B, et al. Loss of collagen-receptor DDR1 delaysrenalfibrosis in hereditary type IV collagendisease. Matrix Biol.2010;29:346-56.
    Open DOISearch in Google Scholar
  21. 21. Avivi-Green C, Singal M, Vogel WF. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Am J RespirCrit Care Med. 2006;174:420-27.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/jccm-2015-0015 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 92 - 95
Submitted on: Mar 20, 2015
Accepted on: Jun 19, 2015
Published online: Aug 6, 2015
Published in print: May 1, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
renal fibrosis,
renal inflammation,
DDR1,
periostin
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2015 Niki Prakoura, Panos Kavvadas, Christos Chatziantoniou, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 1 (2015): Issue 3 (July 2015)
Previous article
Next article